Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1CNS 1Breast 1

Conditions

Liver Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Cyclophosphamide 909Carboplatin 787pembrolizumab 744Paclitaxel 742Cisplatin 709Bevacizumab 706Gemcitabine 619Docetaxel 579Rituximab 548Radiotherapy 541Dexamethasone 511Nivolumab 488Doxorubicin 444Fluorouracil 392Capecitabine 376Etoposide 358Pemetrexed 337Cytarabine 335Oxaliplatin 333Lenalidomide 328Prednisone 326fludarabine phosphate 316Erlotinib Hydrochloride 314Trastuzumab 300Leucovorin 299fludarabine 296Vincristine 287Filgrastim 284Bortezomib 284Cetuximab 276

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Has results × gadobenic acid × Clear all
NCT03703492 2025-02-12

Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS

University of Wisconsin, Madison

Phase 2 Completed
12 enrolled 9 charts
Breast

Breast Neoplasms

NCT00395863 2020-11-05

Multihance at 3 Tesla (3T) in Brain Tumors

Bracco Diagnostics, Inc

Phase 4 Completed
46 enrolled 18 charts
CNS

Brain Neoplasms

NCT00539253 2017-09-26

TACE

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Completed
45 enrolled 5 charts
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡